Back
Oramed Pharmaceuticals Stock Price Chart
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
39
ORMP
Oramed Pharmaceuticals
Last Price:
2.31
Seasonality Move:
22.85%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORMP is experiencing slight selling pressure.
Oramed Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.34 | Sell |
| 20-day SMA: | 2.35 | Sell |
| 50-day SMA: | 2.38 | Sell |
| 200-day SMA: | 2.52 | Sell |
| 8-day EMA: | 2.34 | Sell |
| 20-day EMA: | 2.35 | Sell |
| 50-day EMA: | 2.37 | Sell |
| 200-day EMA: | 2.51 | Sell |
Oramed Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 47.89 | Sell |
| Chaikin Money Flow: | -14355 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.33 - 2.39) | Sell |
| Bollinger Bands (100): | (2.33 - 2.51) | Sell |
Oramed Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Oramed Pharmaceuticals Stock
Is Oramed Pharmaceuticals Stock a Buy?
- Oramed Pharmaceuticals share price is 2.34 while ORMP 8-day simple moving average is 2.34, which is a Sell signal.
- The stock price of ORMP is 2.34 while Oramed Pharmaceuticals 20-day SMA is 2.35, which makes it a Sell.
- Oramed Pharmaceuticals 50-day simple moving average is 2.38 while ORMP share price is 2.34, making it a Sell technically.
- ORMP stock price is 2.34 and Oramed Pharmaceuticals 200-day simple moving average is 2.52, creating a Sell signal.
ORMP Technical Analysis vs Fundamental Analysis
Sell
39
Oramed Pharmaceuticals (ORMP)
is a Sell
Is Oramed Pharmaceuticals a Buy or a Sell?
-
Oramed Pharmaceuticals stock is rated a Sell
The current Oramed Pharmaceuticals [ORMP] share price is $2.34. The Score for ORMP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Oramed Pharmaceuticals Stock Info
Market Cap:
95.2M
Price in USD:
2.34
Share Volume:
104.07K
Oramed Pharmaceuticals 52-Week Range
52-Week High:
3.67
52-Week Low:
2.00
Sell
39
Oramed Pharmaceuticals (ORMP)
is a Sell
Oramed Pharmaceuticals Share Price Forecast
-
What is the Oramed Pharmaceuticals stock price today?
The Oramed Pharmaceuticals stock price is 2.34 USD today. -
Will ORMP stock go up or go down?
Oramed Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Oramed Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Oramed Pharmaceuticals is overvalued.
Is Oramed Pharmaceuticals Stock a Buy?
- Oramed Pharmaceuticals share price is 2.34 while ORMP 8-day exponential moving average is 2.34, which is a Sell signal.
- The stock price of ORMP is 2.34 while Oramed Pharmaceuticals 20-day EMA is 2.35, which makes it a Sell.
- Oramed Pharmaceuticals 50-day exponential moving average is 2.37 while ORMP share price is 2.34, making it a Sell technically.
- ORMP stock price is 2.34 and Oramed Pharmaceuticals 200-day simple moving average is 2.51, creating a Sell signal.
Fundamental Analysis of Oramed Pharmaceuticals
Is Oramed Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and a decrease next year of $0.43 per share.
Technical Analysis of Oramed Pharmaceuticals
Should I short Oramed Pharmaceuticals stock?
- ORMP Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Oramed Pharmaceuticals is a Sell
- Oramed Pharmaceuticals Relative Strength Index (RSI) is 47.89, which suggest Oramed Pharmaceuticals is oversold
- The Bollinger Bands (25) for Oramed Pharmaceuticals is (2.33 - 2.39), which suggest Oramed Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Oramed Pharmaceuticals is (2.33 - 2.51), which suggest Oramed Pharmaceuticals is a Sell
* Oramed Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.